GILD Gilead Sciences
- Official Name: GILEAD SCIENCES, INC.
- Headquarters: 333 LAKESIDE DR, FOSTER CITY, CA, 94404-1147 US
- CEO: Daniel P. O'Day
- Website: gilead.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-14 | 1 | Lost by 0.483 | (1.466) - (0.983) | ||
| 2025-07-21 | 2 | Lost by 16.974 | (3.897) - 13.077 | ||
| 2025-07-28 | 3 | Won by 11.208 | 5.193 - (6.015) | ||
| 2025-07-29 | 2R | Won by 6.005 | 3.122 - (2.883) | ||
| 2025-08-04 | 4 | Won by 10.866 | 3.757 - (7.109) | ||
| 2025-08-06 | 1R | Lost by 2.037 | (1.575) - 0.462 | ||
| 2025-08-07 | 1R | Lost by 2.313 | (0.037) - 2.276 | ||
| 2025-08-11 | 5 | Lost by 9.440 | 4.369 - 13.809 | ||
| 2025-08-12 | 3R | Lost by 2.600 | (0.140) - 2.460 | ||
| 2025-08-18 | 6 | Lost by 1.131 | (0.968) - 0.163 | ||
| 2025-08-25 | 7 | Lost by 12.477 | (2.231) - 10.246 | ||
| 2025-09-01 | 8 | Lost by 2.403 | (1.026) - 1.377 | ||
| 2025-09-08 | 9 | Won by 2.447 | 2.716 - 0.269 | ||
| 2025-09-15 | 10 | Lost by 1.432 | (2.705) - (1.273) | ||
| 2025-09-22 | 11 | Lost by 7.729 | (0.044) - 7.685 | ||
| 2025-09-29 | 12 | Won by 0.133 | 0.114 - (0.019) | ||
| 2025-10-06 | 13 | Won by 5.571 | 0.719 - (4.852) | ||
| 2025-10-13 | 14 | Won by 1.694 TOTW | 3.790 - 2.096 | ||
| 2025-10-20 | 15 | Won by 2.549 | 4.238 - 1.689 |
Latest News
Yahoo - 2026-09-28
Can Lenacapavir Power Gilead Sciences (GILD)’s Next Growth Phase?
On September 16, Gilead Sciences, Inc. (NASDAQ:GILD) expanded the scope of its six royalty-free voluntary licensing agreements for lenacapavir to cove...
Yahoo - 2026-09-28
Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside?
At first glance, Gilead Sciences, Inc. (NASDAQ:GILD) and Intuitive Surgical, Inc. (NASDAQ:ISRG) don’t make for the most obvious comparison. One sell...
Yahoo - 2026-09-28
Gilead vs. Danaher: Which Healthcare Growth Story is More Convincing?
Gilead Sciences, Inc. (NASDAQ:GILD) and Danaher Corporation (NYSE:DHR) are both showing signs of stronger growth, but they are getting there in very d...
Yahoo - 2026-09-28
Gilead vs. Thermo Fisher: Which Life Sciences Stock has the Stronger Growth Outlook?
Gilead Sciences, Inc. (NASDAQ:GILD) and Thermo Fisher Scientific Inc. (NYSE:TMO) are benefiting from two very different sources of growth. Gilead’s ...
Yahoo - 2026-09-28
Can Gilead Sciences (GILD) Justify Its Price As It Raises 2026 Guidance And Dividend?
Gilead Sciences (GILD) has put fresh numbers on the table, raising its 2026 sales outlook and lifting its quarterly dividend by 3.8%, a combination th...
Yahoo - 2026-09-27
Gilead vs. Medtronic: Which Healthcare Stock Offers the Better Mix of Growth and Income?
Gilead Sciences, Inc. (NASDAQ:GILD) and Medtronic plc (NYSE:MDT) both combine growing healthcare businesses with regular cash returns to shareholders,...
Yahoo - 2026-09-27
Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward?
Gilead Sciences, Inc. (NASDAQ:GILD) and Abbott Laboratories (NYSE:ABT) both return cash to shareholders through dividends, but the businesses supporti...
Yahoo - 2026-09-27
Gilead or Johnson & Johnson: Is Faster Growth Better than Greater Diversification?
Gilead Sciences, Inc. (NASDAQ:GILD) and Johnson & Johnson (NYSE:JNJ) offer investors two very different versions of pharmaceutical growth. Gilead ...
Yahoo - 2026-09-27
Gilead’s HIV Concentration or Pfizer’s Patent Cliff: Which Risk is Easier to Own?
Pfizer Inc. (NYSE:PFE) and Gilead Sciences, Inc. (NASDAQ:GILD) present investors with two very different forms of concentration risk. Pfizer needs new...
SeekingAlpha - 2026-09-25
Dividend Champion, Contender, And Challenger Highlights: Week September 27
Get the weekly summary of dividend changes for Dividend Champions, Contenders & Challengers, plus upcoming ex-dividend and pay dates.
Benzinga - 2026-09-24
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transac...
Show more
SeekingAlpha - 2026-09-23
Gilead: HIV Growth Is Not Enough At The Current Price
Yahoo - 2026-09-22
Gilead Sciences (GILD) Stock Moves 1.40%: What You Should Know
Yahoo - 2026-09-22
1 Cash-Producing Stock on Our Buy List and 2 We Find Risky
CNBC - 2026-09-22
Novo defends diversification push as CEO eyes deals beyond obesity
Yahoo - 2026-09-21
BMY vs GILD: Which Biotech Stock Looks More Attractive Now?
Yahoo - 2026-09-21
Novo Nordisk Stock Drops 5.6% as 2030 Goals Match Peers
Benzinga - 2026-09-21
Here's How Much $1000 Invested In Gilead Sciences 5 Years Ago Would Be Worth Today
CNBC - 2026-09-21
Novo shares slide as drugmaker lays out post-Wegovy growth strategy
Yahoo - 2026-09-20
Why Morgan Stanley likes Gilead's HIV prevention play
Yahoo - 2026-09-18
4 Biotech Stocks to Watch as Potential Takeover Targets
Yahoo - 2026-09-18
J&J Up 18% in Three Months: Buy, Sell or Hold the Stock?
SeekingAlpha - 2026-09-18
5 Undervalued Oncology Stocks Wall Street Is Overlooking
Yahoo - 2026-09-17
Latin America’s PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF
Yahoo - 2026-09-17
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
Yahoo - 2026-09-16
Gilead Expands Lenacapavir Access With New PAHO Deal in Latin America
Yahoo - 2026-09-16
Gilead Expands Lenacapavir Licensing Agreements to Include Once-Yearly HIV Prevention Formulation
Yahoo - 2026-09-16
Gilead Accelerates Global Access Planning for Investigational Once-Yearly Lenacapavir for HIV Prevention
Yahoo - 2026-09-15
Sector Update: Healthcare Stocks Ease Late Afternoon
Yahoo - 2026-09-15
Sector Update: Healthcare Stocks Lower Tuesday Afternoon
Yahoo - 2026-09-15
Gilead and PAHO Announce Milestone Partnership to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention Across Latin America and the Caribbean
SeekingAlpha - 2026-09-15
Gilead Sciences, Inc. (GILD) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Benzinga - 2026-09-15
Gilead And PAHO Partner To Expand Twice-Yearly Lenacapavir HIV Prevention Access Across Latin America And The Caribbean
Benzinga - 2026-09-15
Gilead Exec Says HIV Market Growth Should Normalize To 2%-3% Within Next Couple Of Quarters
Benzinga - 2026-09-15
Gilead Sciences Exec Says Weekly Oral HIV Prevention Drug Expected To Launch In Q1 2027
Yahoo - 2026-09-15
Gilead Sciences Inc's Dividend Analysis
Yahoo - 2026-09-14
Is Gilead Sciences (GILD) Reasonable Given Its Sales Base?
Yahoo - 2026-09-14
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
Yahoo - 2026-09-11
Gilead Wins Appeals Court Ruling Blocking Imported HIV Drug Sales
SeekingAlpha - 2026-09-11
Dividend Champion, Contender, And Challenger Highlights: Week September 13
Benzinga - 2026-09-10
If You Invested $100 In Gilead Sciences Stock 20 Years Ago, You Would Have This Much Today
Yahoo - 2026-09-10
Gilead Sciences Sees Sunlenca Launch Fueling Long-Term HIV Growth
SeekingAlpha - 2026-09-10
Gilead Sciences, Inc. (GILD) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
Yahoo - 2026-09-10
Here's Why You Should Add NRIX Stock to Your Portfolio Now
Benzinga - 2026-09-10
HSBC Maintains Buy on Gilead Sciences, Raises Price Target to $175
SeekingAlpha - 2026-09-09
Gilead Sciences, Inc. (GILD) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Yahoo - 2026-09-09
Will The Recent Pipeline Progress Boost BMY's Portfolio Expansion?
Yahoo - 2026-09-09
Sofinnova Investments Announces the Appointment of Dr. Merdad Parsey as Executive Partner
Yahoo - 2026-09-09
1 S&P 500 Stock on Our Buy List and 2 Facing Challenges
Yahoo - 2026-09-09
Gilead launches research facility in US for new medicine development
SeekingAlpha - 2026-09-09
MacroGenics: Inexpensive ADC/TCE Biotech With Multiple Catalysts Ahead
Yahoo - 2026-09-08
Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights
Yahoo - 2026-09-08
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
Yahoo - 2026-09-08
Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines
CNBC - 2026-09-08
AstraZeneca’s COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes
Yahoo - 2026-09-07
Bixlenvo Gives Gilead a New HIV Growth Path. How Large is the Market?
Yahoo - 2026-09-07
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party?
Yahoo - 2026-09-05
Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?
Yahoo - 2026-09-04
Will New HIV and Oncology Approvals Redefine Gilead Sciences' (GILD) Treatment Platform Narrative?
ChartMill - 2026-09-04
Gilead Sciences (NASDAQ:GILD): A Quality Dividend Stock for Income Investors
Yahoo - 2026-09-04
Gilead’s growing HIV franchise; cell therapy licensing deals plummet
Yahoo - 2026-09-03
Why Is Gilead (GILD) Up 13.6% Since Last Earnings Report?
Yahoo - 2026-09-03
Is Gilead Sciences Stock Outperforming the S&P 500?
Yahoo - 2026-09-02
Can LLY's Merida Deal Boost Its M&A Push to Diversify Beyond GLP-1s?
Yahoo - 2026-09-01
Top Research Reports for Toyota Motor, CrowdStrike & Welltower
Yahoo - 2026-09-01
Can Bixlenvo Unlock New Growth for Gilead's HIV Business?
Yahoo - 2026-09-01
Gilead (GILD) Upgraded to Strong Buy: What Does It Mean for the Stock?
Yahoo - 2026-09-01
Wall Street Analysts See Gilead (GILD) as a Buy: Should You Invest?
Yahoo - 2026-08-31
Cocrystal Pharma: The Strategic Reset Investors May Be Missing
SeekingAlpha - 2026-08-31
Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
Yahoo - 2026-08-31
3 Unpopular Stocks with Open Questions
Benzinga - 2026-08-31
FDA Approves Gilead's New Single Tablet HIV Regimen
SeekingAlpha - 2026-08-31
Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs
Yahoo - 2026-08-28
Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection
Yahoo - 2026-08-27
Gilead (GILD) Stock Looks Undervalued After A 147% Five Year Run
Yahoo - 2026-08-27
U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex Regimens
ChartMill - 2026-08-27
What's going on in today's after hours session: S&P500 movers
CNBC - 2026-08-27
FDA approves Gilead's daily HIV pill
Benzinga - 2026-08-27
Gilead Sciences Announces FDA Approval For Bixlenvo, The Smallest Once-Daily Single Tablet Regimen For The Treatment Of HIV In Adults Who Are Virologically Suppressed
CNBC - 2026-08-27
FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients
Yahoo - 2026-08-27
What Does Gilead Sciences (GILD) Gain From Its Expanded EU Breast Cancer Approval?
SeekingAlpha - 2026-08-27
GSK: Still One Of My Top Healthcare Picks
Yahoo - 2026-08-26
Gilead Sciences Has Snapped Out of Its Slump -- and 1 Catalyst Is Doing Most of the Heavy Lifting
Yahoo - 2026-08-26
Vivace Therapeutics names new CEO as it prepares Phase 3 trial for mesothelioma drug
Yahoo - 2026-08-25
Eli Lilly Is Pulling Away From the Rest of Healthcare
Yahoo - 2026-08-25
3 Dividend Stocks to Hold for the Next 10 Years
Yahoo - 2026-08-25
3 Unprofitable Stocks with Questionable Fundamentals
Yahoo - 2026-08-24
GILD Stock Garners Retail Attention On Trodelvy EU Approval Ahead Of August 27 HIV FDA Verdict
Yahoo - 2026-08-24
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
Yahoo - 2026-08-24
Exelixis Owners Keep Getting A Bigger Slice Of A Company In Transition
Benzinga - 2026-08-24
$1000 Invested In Gilead Sciences 5 Years Ago Would Be Worth This Much Today
Yahoo - 2026-08-24
European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across PD-L1 Status
Benzinga - 2026-08-24
Gilead’s Trodelvy-Keytruda Combo Gets EU Approval for Metastatic Breast Cancer
Yahoo - 2026-08-23
Gilead’s Core Business Is Accelerating, But Will Its $11 Billion Pipeline Bet Pay Off?
Yahoo - 2026-08-21
Making Drugs With AI: Biopharma Giants Gear Up For New Arena
Yahoo - 2026-08-20
Does Gilead (GILD) Pairing With Nucleai Reveal a Deeper Shift in Its Oncology Strategy?
Yahoo - 2026-08-19
Biotech Stocks Are Booming. What This Top Fund Is Buying Now.
Yahoo - 2026-08-19
HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
Yahoo - 2026-08-18
Is Gilead's Expanding HIV Portfolio a Growth Catalyst?
Yahoo - 2026-08-18
Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.
Yahoo - 2026-08-17
Gilead yanks out a thorn in its side in major court ruling
Yahoo - 2026-08-16
Gilead Sciences (GILD): Buy, Sell, or Hold Post Q2 Earnings?
SeekingAlpha - 2026-08-16
Assembly Biosciences: Gilead Advancements For GS-1179 And ABI-6250 Is A Bullish Signal
Yahoo - 2026-08-14
Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?
Yahoo - 2026-08-14
Gilead wins appeals court ruling against overseas drug imports
Yahoo - 2026-08-14
BofA biotech scorecard: Two buys and odd one out
CNBC - 2026-08-14
Court rules companies can't import Gilead medications from overseas in blow to AFP health programs
Yahoo - 2026-08-13
Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engine
Yahoo - 2026-08-13
Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates
Yahoo - 2026-08-13
Gilead (GILD) Stock Still Looks Cheap On Sales Despite A 127% Run
Yahoo - 2026-08-13
Why Gilead Sciences (GILD) Is Back In The Spotlight
Yahoo - 2026-08-13
5 Must-Read Analyst Questions From Gilead Sciences’s Q2 Earnings Call
Yahoo - 2026-08-12
Gilead Sciences (GILD) Expands ADC Research With AI Tissue Analytics
Yahoo - 2026-08-12
TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses
Benzinga - 2026-08-12
KLA, Snowflake, Airbnb And A Health Care Stock On CNBC’s ‘Final Trades’
Yahoo - 2026-08-11
3 Healthcare Stocks with Open Questions
Yahoo - 2026-08-11
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
Benzinga - 2026-08-11
If You Invested $1000 In Gilead Sciences Stock 20 Years Ago, You Would Have This Much Today
Yahoo - 2026-08-11
J&J Trading Above 200- & 50-Day SMAs: Buy, Sell or Hold the Stock?
Benzinga - 2026-08-11
Snowflake shares are trading lower. The company announced the appointment of Jonathan Beaulier as Chief Revenue Officer and reaffirmed its FY27 guidance.
Yahoo - 2026-08-11
Nucleai Advances AI-Powered Tissue Intelligence Through Large-Scale Oncology ADC Collaboration
Yahoo - 2026-08-10
Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update
SeekingAlpha - 2026-08-10
Gilead Sciences: The Market May Be Underestimating Its Growth (Rating Upgrade)
Yahoo - 2026-08-10
GILD- An Attractive Biotech Stock with Solid Base Revenue Growth
Yahoo - 2026-08-08
Key HIV stat over 70% leaves BofA siding with Gilead
Yahoo - 2026-08-07
What Insmed Stock's Premium Is Actually Buying
Yahoo - 2026-08-07
GILD Q2 Earnings Call Raises Outlook on HIV and PrEP Strength
SeekingAlpha - 2026-08-07
Amgen: The Market Is Underestimating Its Next Growth Phase
Yahoo - 2026-08-06
KYMR Q2 Earnings and Revenues Top Estimates on Gilead, Sanofi Payments
SeekingAlpha - 2026-08-06
Gilead Sciences: A Strong Quarter Hidden Behind Ugly Earnings
Benzinga - 2026-08-05
Kathy Hochul Slams Trump Over Medicare Cut, Says 1.3 Million New Yorkers Will Pay More for Prescriptions: 'A New Assault on Seniors...'
Yahoo - 2026-08-05
Compass Pathways PLC (CMPS) (Q2 2026) Earnings Call Highlights: Strong Cash Position and NDA ...
Yahoo - 2026-08-05
Kymera Therapeutics Q2 Earnings Call Highlights
Yahoo - 2026-08-05
Gilead Slumps As Long-Term Uncertainty Clouds Massive HIV Beat
Benzinga - 2026-08-05
RBC Capital Maintains Sector Perform on Gilead Sciences, Raises Price Target to $123
Yahoo - 2026-08-05
The Bull Case For Gilead Sciences (GILD) Could Change Following Deeper 2026 Losses Amid HIV, Oncology Growth
Yahoo - 2026-08-05
Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launch
Benzinga - 2026-08-05
Cantor Fitzgerald Reiterates Overweight on Gilead Sciences, Maintains $155 Price Target
Benzinga - 2026-08-05
Needham Reiterates Buy on Gilead Sciences, Maintains $170 Price Target
Yahoo - 2026-08-05
Gilead Sciences Inc (GILD) (Q2 2026) Earnings Call Highlights: PrEP Sales Double to $1B, HIV ...
ChartMill - 2026-08-04
Gilead Sciences (NASDAQ:GILD) Posts Q2 Beat but Stock Slips on Full-Year Guidance
Yahoo - 2026-08-04
Gilead Sciences Q2 Earnings Call Highlights
Yahoo - 2026-08-04
Compared to Estimates, Gilead (GILD) Q2 Earnings: A Look at Key Metrics
SeekingAlpha - 2026-08-04
Gilead Sciences, Inc. (GILD) Q2 2026 Earnings Call Transcript
Yahoo - 2026-08-04
Gilead Sciences (GILD) Reports Q2 Loss, Beats Revenue Estimates
Yahoo - 2026-08-04
AHF Crowns Gilead Corporate Welfare King
Yahoo - 2026-08-04
Gilead Sciences (NASDAQ:GILD) Beats Expectations in Strong Q2 CY2026
Yahoo - 2026-08-04
Gilead Posts a Loss on Acquisitions but Revenue Tells a Bigger Story
Yahoo - 2026-08-04
Why Gilead's High-Profile HIV Drug Might Have To Play Catch-Up
Yahoo - 2026-08-04
Gilead Sciences Announces Second Quarter 2026 Financial Results
Yahoo - 2026-08-04
Equities Rally Intraday Amid Upbeat Earnings, Hormuz Reopening Hopes
Yahoo - 2026-08-04
Merck's Weekly HIV Treatment Pipeline 'Interesting,' UBS Says
SeekingAlpha - 2026-08-04
Gilead Sciences, Inc. 2026 Q2 - Results - Earnings Call Presentation
Benzinga - 2026-08-04
Gilead Sciences Lowers FY2026 GAAP EPS Guidance from $(3.25)-$(2.85) to $(3.75)-$(3.40) vs $(2.77) Est
Benzinga - 2026-08-04
Gilead Sciences Q2 Adj. EPS $(6.75) Beats $(7.24) Estimate, Sales $7.803B Beat $7.400B Estimate
Yahoo - 2026-08-04
Could Gilead Sciences (GILD) Have a Major HIV Growth Engine in Yeztugo?
Yahoo - 2026-08-04
Gilead Sciences, Inc. Q2 2026 Earnings Call Summary
Yahoo - 2026-08-04
Compugen Ltd. Q2 2026 Earnings Call Summary
Yahoo - 2026-08-04
Rani Therapeutics Appoints Michelle Gilson to Board of Directors
Yahoo - 2026-08-04
Stocks Rise Pre-Bell Ahead of Latest Round of Earnings; Investors Gauge Uncertainty Over Potential US-Iran Deal
CNBC - 2026-08-03
Goldman Sachs's Hader on why AstraZeneca's stock fell on news of possible merger with Bristol Myers
Yahoo - 2026-08-03
Gilead Sciences (GILD) Q2 Earnings Report Preview: What To Look For
Benzinga - 2026-08-03
SpaceX Could Swing $204 Billion After Earnings
CNBC - 2026-08-03
AstraZeneca–Bristol Myers Squibb merger 'is not highly likely to happen,' says UBS' Michael Yee
Benzinga - 2026-08-03
"California Supreme Court Rules In Favor Of Gilead Sciences In 'Duty To Innovate' Case Involving HIV Drugs" - Reuters
Yahoo - 2026-08-03
Falling Oil Boosts Wall Street Pre-Bell; Asia Mixed, Europe Up
Yahoo - 2026-08-03
Compugen Reports Second Quarter 2026 Results
Benzinga - 2026-08-03
Eli Lilly Could Swing Over $76 Billion In Value After Earnings
Yahoo - 2026-07-31
Is The Recent Pullback In Alnylam Stock An Opportunity Or A Trap?
Yahoo - 2026-07-31
2 Large-Cap Stocks for Long-Term Investors and 1 Facing Challenges
Yahoo - 2026-07-30
Seeking Clues to Gilead (GILD) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Yahoo - 2026-07-30
Is Most-Watched Stock Gilead Sciences, Inc. (GILD) Worth Betting on Now?
Yahoo - 2026-07-30
Do Wall Street Analysts Like Gilead Sciences Stock?
Yahoo - 2026-07-30
Gilead (GILD) Stock Stays Cheap On Its 130% Five Year Run
SeekingAlpha - 2026-07-30
Gilead: Buy The Distortion Before Q2 Clears It Up
Yahoo - 2026-07-29
Gilead to Report Q2 Earnings: How Should You Play the Stock Now?
Yahoo - 2026-07-29
Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out for
Yahoo - 2026-07-29
BMS and Gilead rule in the CAR-T space. Off-the-shelf developers aren’t trying to change that.
Benzinga - 2026-07-29
Barclays Maintains Equal-Weight on Gilead Sciences, Lowers Price Target to $145
Yahoo - 2026-07-28
Gilead Sciences (GILD) Laps the Stock Market: Here's Why
Yahoo - 2026-07-28
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
Benzinga - 2026-07-28
4 Health Care Stocks With Whale Alerts In Today’s Session
Yahoo - 2026-07-28
Atea Pharmaceuticals Says Combination Drug Meets Endpoints in Phase 3 Hepatitis C Trial
Yahoo - 2026-07-28
Transforming Bioprocessing for the Digital Age Takes Center Stage at the Bioprocessing Summit 2026
Yahoo - 2026-07-28
Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development
Benzinga - 2026-07-27
Morgan Stanley Maintains Overweight on Gilead Sciences, Lowers Price Target to $165
Yahoo - 2026-07-24
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
ChartMill - 2026-07-24
Gilead Sciences Inc (NASDAQ:GILD): A Quality Dividend Stock for Income Investors
Yahoo - 2026-07-24
CHMP Recommends Gilead’s Trodelvy® Plus Keytruda® in PD-(L)1-Positive First-Line Metastatic Triple-Negative Breast Cancer
SeekingAlpha - 2026-07-24
Legend Biotech: Why I'm Ready To Go Long Again
Benzinga - 2026-07-24
Gilead Receives EMA CHMP Recommendation For Authorization For Trodelvy Plus Keytruda To Treat Metastatic Triple-Negative Breast Cancer
Benzinga - 2026-07-24
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
Yahoo - 2026-07-23
Can Gilead's Efforts to Develop New Treatments Solidify HIV Franchise?
Yahoo - 2026-07-22
Gilead (GILD) Will Bring New HIV Data And A Merck Regimen To AIDS 2026
Yahoo - 2026-07-21
Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
Yahoo - 2026-07-21
3 Market-Beating Stocks with Solid Fundamentals
Yahoo - 2026-07-21
Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure
Benzinga - 2026-07-21
Gilead, Merck Advance Potential Blockbuster Weekly HIV Pill
Yahoo - 2026-07-21
Gilead Sciences' Quarterly Earnings Preview: What You Need to Know
Benzinga - 2026-07-21
Leerink Partners Downgrades Gilead Sciences to Market Perform, Lowers Price Target to $127
Yahoo - 2026-07-21
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Adobe, Datadog, Five Below, Fortinet, Gilead Sciences, Goldman Sachs, Microsoft, Salesforce, and More
Benzinga - 2026-07-20
Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
Yahoo - 2026-07-17
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Yahoo - 2026-07-17
Gilead Leads The Battle Vs. HIV. But Rivals Are On The Move.
Yahoo - 2026-07-16
Kalshi Allows Betting On Clinical Trials And FDA Drug Decisions
Benzinga - 2026-07-16
Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings
Yahoo - 2026-07-16
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Yahoo - 2026-07-16
Kalshi Will Offer Sports-Style Betting on Drug Trial Results
Yahoo - 2026-07-13
Own Regeneron For Biotech Growth? Incyte Is Making Its Case.
Yahoo - 2026-07-12
Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong.
Yahoo - 2026-07-10
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
ChartMill - 2026-07-10
What's going on in today's session: S&P500 movers
Yahoo - 2026-07-10
2 Recession-Resistant Dividend Stocks to Buy and Hold
Yahoo - 2026-07-09